Human Whole Genome Sequencing

Whole-genome analysis for human genetic variation, disease research, population genomics and complex disease studies.

Human whole genome sequencing (hWGS) gives researchers a genome-wide view of human genetic variation, from SNPs and indels to copy number and structural variants. It supports genomics research across inherited disease, cancer biology, population genetics and complex disease mechanisms.

Novogene Europe provides hWGS as part of its broader multi-omics service portfolio, combining high-throughput sequencing, quality control and bioinformatics support to help researchers generate reliable, analysis-ready data for human genomics studies.

Service Highlights

Broader Variant Discovery

Detect SNPs, indels, copy number variants and structural variants across coding and non-coding regions for a genome-wide view of human genetic variation.

Flexible Sequencing Strategy

Select short-read or long-read sequencing based on project goals, from scalable variant detection to complex or repetitive region characterisation.

Consistent Data Quality

hWGS supports population-scale studies by enabling comparison of genetic variation across individuals, cohorts and ancestry groups at scale.

Bioinformatics Support

Bioinformatics analysis and clear data outputs support variant interpretation, population studies and disease-focused research applications.

Applications

Inherited Disease Research

hWGS can support studies of rare and inherited diseases by helping researchers investigate genetic variants associated with unexplained or complex clinical phenotypes.

Cancer Genomics

Whole genome data can help researchers study tumour biology, driver mutations, structural alterations and broader genomic changes involved in cancer development and progression.

Population Genomics

hWGS supports population-scale studies by enabling comparison of genetic variation across individuals, cohorts and ancestry groups in large datasets.

Complex Disease Studies

By capturing genome-wide variation, hWGS can support research into complex disease mechanisms where multiple genetic factors may contribute to biological or clinical outcomes.

Specifications

Sample Requirements

The quantities listed are provided for reference only. Please download the Sample Requirements for detailed guidance, or contact us to discuss your project-specific requirements.

Platform Type	Sample Type	Amount (Qubit®)	Purity
Illumina NovaSeq X Plus /NovaSeq6000	Genomic DNA	≥100 ng	OD260/280 = 1.8-2.0. no degradation, no contamination Fragments longer than 1000 bp
	Genomic DNA (PCR free)	≥ 1.2 μg
	Genomic DNA from FFPE tissue	≥ 300 ng	Fragments longer than 1000 bp
PacBio Revio DNA HiFi library	HMW Genomic DNA	≥ 3 μg	OD260/280=1.75-2.0; OD260/230=1.5-2.6; *NC/QC=1.0-2.2Fragments should be ≥ 30 kb
PacBio PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band (PacBio library fragments distributed above 1k)
Nanopore PromethION DNA library	HMW Genomic DNA	≥ 8 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore Ultra-long DNA Library	uHMW Genomic DNA (blood and cells)	≥ 30 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band

*NC/QC: NanoDrop concentration/Qubit concentration

Sample Requirements

The quantities listed are provided for reference only. Please download the Sample Requirements for detailed guidance, or contact us to discuss your project-specific requirements.

Platform Type	Sample Type	Amount (Qubit®)	Purity
Illumina NovaSeq X Plus /NovaSeq6000	Genomic DNA	≥100 ng	OD260/280 = 1.8-2.0. no degradation, no contamination Fragments longer than 1000 bp
	Genomic DNA (PCR free)	≥ 1.2 μg
	Genomic DNA from FFPE tissue	≥ 300 ng	Fragments longer than 1000 bp
PacBio Revio DNA HiFi library	HMW Genomic DNA	≥ 3 μg	OD260/280=1.75-2.0; OD260/230=1.5-2.6; *NC/QC=1.0-2.2Fragments should be ≥ 30 kb
PacBio PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band (PacBio library fragments distributed above 1k)
Nanopore PromethION DNA library	HMW Genomic DNA	≥ 8 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore Ultra-long DNA Library	uHMW Genomic DNA (blood and cells)	≥ 30 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band

*NC/QC: NanoDrop concentration/Qubit concentration

Sample Requirements

The quantities listed are provided for reference only. Please download the Sample Requirements for detailed guidance, or contact us to discuss your project-specific requirements.

Platform Type	Sample Type	Amount (Qubit®)	Purity
Illumina NovaSeq X Plus /NovaSeq6000	Genomic DNA	≥100 ng	OD260/280 = 1.8-2.0. no degradation, no contamination Fragments longer than 1000 bp
	Genomic DNA (PCR free)	≥ 1.2 μg
	Genomic DNA from FFPE tissue	≥ 300 ng	Fragments longer than 1000 bp
PacBio Revio DNA HiFi library	HMW Genomic DNA	≥ 3 μg	OD260/280=1.75-2.0; OD260/230=1.5-2.6; *NC/QC=1.0-2.2Fragments should be ≥ 30 kb
PacBio PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band (PacBio library fragments distributed above 1k)
Nanopore PromethION DNA library	HMW Genomic DNA	≥ 8 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore Ultra-long DNA Library	uHMW Genomic DNA (blood and cells)	≥ 30 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band

*NC/QC: NanoDrop concentration/Qubit concentration

Sample Requirements

The quantities listed are provided for reference only. Please download the Sample Requirements for detailed guidance, or contact us to discuss your project-specific requirements.

Platform Type	Sample Type	Amount (Qubit®)	Purity
Illumina NovaSeq X Plus /NovaSeq6000	Genomic DNA	≥100 ng	OD260/280 = 1.8-2.0. no degradation, no contamination Fragments longer than 1000 bp
	Genomic DNA (PCR free)	≥ 1.2 μg
	Genomic DNA from FFPE tissue	≥ 300 ng	Fragments longer than 1000 bp
PacBio Revio DNA HiFi library	HMW Genomic DNA	≥ 3 μg	OD260/280=1.75-2.0; OD260/230=1.5-2.6; *NC/QC=1.0-2.2Fragments should be ≥ 30 kb
PacBio PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band (PacBio library fragments distributed above 1k)
Nanopore PromethION DNA library	HMW Genomic DNA	≥ 8 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore Ultra-long DNA Library	uHMW Genomic DNA (blood and cells)	≥ 30 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band

*NC/QC: NanoDrop concentration/Qubit concentration

Sequencing and Analysis

Recommended data outputs and analysis examples are provided for reference only. For detailed information, please contact us to discuss your project-specific analysis requirements.

Platform Type	Illumina NovaSeq X Plus	PacBio Revio	Nanopore PromethION
Read Length	Paired-end 150 bp	> 15 kb (Average)	> 17 kb (Average)
Sequencing Depth	For rare diseases: 30-50×	For genetic diseases: 10-20×	For genetic diseases: 10-20×
Sequencing Depth	For tumor tissues: 50×; For adjacent normal tissues and blood: 30×	For tumor tissues: ≥20×	For tumor tissues: ≥20×
Standard Data｜ Analysis	Data quality control Alignment with reference genome SNP/InDel/SV/CNV detection Somatic SNP/InDel/SV/CNV detection (For tumor-normal paired samples)	Data quality control Sequence alignment Structural variant (SV) detection Variation annotation

Note: Values of sequencing depths are only listed for your reference. Download the Service Specifications to learn more. For detailed information, please contact us for your customized requests.

Sequencing and Analysis

Recommended data outputs and analysis examples are provided for reference only. For detailed information, please contact us to discuss your project-specific analysis requirements.

Platform Type	Illumina NovaSeq X Plus	PacBio Revio	Nanopore PromethION
Read Length	Paired-end 150 bp	> 15 kb (Average)	> 17 kb (Average)
Sequencing Depth	For rare diseases: 30-50×	For genetic diseases: 10-20×	For genetic diseases: 10-20×
Sequencing Depth	For tumor tissues: 50×; For adjacent normal tissues and blood: 30×	For tumor tissues: ≥20×	For tumor tissues: ≥20×
Standard Data｜ Analysis	Data quality control Alignment with reference genome SNP/InDel/SV/CNV detection Somatic SNP/InDel/SV/CNV detection (For tumor-normal paired samples)	Data quality control Sequence alignment Structural variant (SV) detection Variation annotation

Note: Values of sequencing depths are only listed for your reference. Download the Service Specifications to learn more. For detailed information, please contact us for your customized requests.

Sequencing and Analysis

Recommended data outputs and analysis examples are provided for reference only. For detailed information, please contact us to discuss your project-specific analysis requirements.

Platform Type	Illumina NovaSeq X Plus	PacBio Revio	Nanopore PromethION
Read Length	Paired-end 150 bp	> 15 kb (Average)	> 17 kb (Average)
Sequencing Depth	For rare diseases: 30-50×	For genetic diseases: 10-20×	For genetic diseases: 10-20×
Sequencing Depth	For tumor tissues: 50×; For adjacent normal tissues and blood: 30×	For tumor tissues: ≥20×	For tumor tissues: ≥20×
Standard Data｜ Analysis	Data quality control Alignment with reference genome SNP/InDel/SV/CNV detection Somatic SNP/InDel/SV/CNV detection (For tumor-normal paired samples)	Data quality control Sequence alignment Structural variant (SV) detection Variation annotation

Note: Values of sequencing depths are only listed for your reference. Download the Service Specifications to learn more. For detailed information, please contact us for your customized requests.

Sequencing and Analysis

Recommended data outputs and analysis examples are provided for reference only. For detailed information, please contact us to discuss your project-specific analysis requirements.

Platform Type	Illumina NovaSeq X Plus	PacBio Revio	Nanopore PromethION
Read Length	Paired-end 150 bp	> 15 kb (Average)	> 17 kb (Average)
Sequencing Depth	For rare diseases: 30-50×	For genetic diseases: 10-20×	For genetic diseases: 10-20×
Sequencing Depth	For tumor tissues: 50×; For adjacent normal tissues and blood: 30×	For tumor tissues: ≥20×	For tumor tissues: ≥20×
Standard Data｜ Analysis	Data quality control Alignment with reference genome SNP/InDel/SV/CNV detection Somatic SNP/InDel/SV/CNV detection (For tumor-normal paired samples)	Data quality control Sequence alignment Structural variant (SV) detection Variation annotation

Note: Values of sequencing depths are only listed for your reference. Download the Service Specifications to learn more. For detailed information, please contact us for your customized requests.

Specifications

Sample Requirements

The quantities listed are provided for reference only. Please download the Sample Requirements for detailed guidance, or contact us to discuss your project-specific requirements.

Platform Type	Sample Type	Amount (Qubit®)	Purity
Illumina NovaSeq X Plus /NovaSeq6000	Genomic DNA	≥100 ng	OD260/280 = 1.8-2.0. no degradation, no contamination Fragments longer than 1000 bp
	Genomic DNA (PCR free)	≥ 1.2 μg
	Genomic DNA from FFPE tissue	≥ 300 ng	Fragments longer than 1000 bp
PacBio Revio DNA HiFi library	HMW Genomic DNA	≥ 3 μg	OD260/280=1.75-2.0; OD260/230=1.5-2.6; *NC/QC=1.0-2.2Fragments should be ≥ 30 kb
PacBio PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band (PacBio library fragments distributed above 1k)
Nanopore PromethION DNA library	HMW Genomic DNA	≥ 8 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore Ultra-long DNA Library	uHMW Genomic DNA (blood and cells)	≥ 30 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band

*NC/QC: NanoDrop concentration/Qubit concentration

Sample Requirements

The quantities listed are provided for reference only. Please download the Sample Requirements for detailed guidance, or contact us to discuss your project-specific requirements.

Platform Type	Sample Type	Amount (Qubit®)	Purity
Illumina NovaSeq X Plus /NovaSeq6000	Genomic DNA	≥100 ng	OD260/280 = 1.8-2.0. no degradation, no contamination Fragments longer than 1000 bp
	Genomic DNA (PCR free)	≥ 1.2 μg
	Genomic DNA from FFPE tissue	≥ 300 ng	Fragments longer than 1000 bp
PacBio Revio DNA HiFi library	HMW Genomic DNA	≥ 3 μg	OD260/280=1.75-2.0; OD260/230=1.5-2.6; *NC/QC=1.0-2.2Fragments should be ≥ 30 kb
PacBio PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band (PacBio library fragments distributed above 1k)
Nanopore PromethION DNA library	HMW Genomic DNA	≥ 8 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore Ultra-long DNA Library	uHMW Genomic DNA (blood and cells)	≥ 30 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band

*NC/QC: NanoDrop concentration/Qubit concentration

Sample Requirements

The quantities listed are provided for reference only. Please download the Sample Requirements for detailed guidance, or contact us to discuss your project-specific requirements.

Platform Type	Sample Type	Amount (Qubit®)	Purity
Illumina NovaSeq X Plus /NovaSeq6000	Genomic DNA	≥100 ng	OD260/280 = 1.8-2.0. no degradation, no contamination Fragments longer than 1000 bp
	Genomic DNA (PCR free)	≥ 1.2 μg
	Genomic DNA from FFPE tissue	≥ 300 ng	Fragments longer than 1000 bp
PacBio Revio DNA HiFi library	HMW Genomic DNA	≥ 3 μg	OD260/280=1.75-2.0; OD260/230=1.5-2.6; *NC/QC=1.0-2.2Fragments should be ≥ 30 kb
PacBio PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band (PacBio library fragments distributed above 1k)
Nanopore PromethION DNA library	HMW Genomic DNA	≥ 8 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore Ultra-long DNA Library	uHMW Genomic DNA (blood and cells)	≥ 30 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band

*NC/QC: NanoDrop concentration/Qubit concentration

Sample Requirements

The quantities listed are provided for reference only. Please download the Sample Requirements for detailed guidance, or contact us to discuss your project-specific requirements.

Platform Type	Sample Type	Amount (Qubit®)	Purity
Illumina NovaSeq X Plus /NovaSeq6000	Genomic DNA	≥100 ng	OD260/280 = 1.8-2.0. no degradation, no contamination Fragments longer than 1000 bp
	Genomic DNA (PCR free)	≥ 1.2 μg
	Genomic DNA from FFPE tissue	≥ 300 ng	Fragments longer than 1000 bp
PacBio Revio DNA HiFi library	HMW Genomic DNA	≥ 3 μg	OD260/280=1.75-2.0; OD260/230=1.5-2.6; *NC/QC=1.0-2.2Fragments should be ≥ 30 kb
PacBio PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band (PacBio library fragments distributed above 1k)
Nanopore PromethION DNA library	HMW Genomic DNA	≥ 8 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore Ultra-long DNA Library	uHMW Genomic DNA (blood and cells)	≥ 30 μg	OD260/280=1.7-2.0; OD260/230=1.3-2.6; *NC/QC=0.95-3.00; Fragments should be ≥ 300K, no fragments below 30k.
Nanopore PCR product library	PCR product	≥ 2 μg	OD260/280=1.75~2.0; OD260/230=1.4~2.6; *NC/QC=0.95~3.00; Single band

*NC/QC: NanoDrop concentration/Qubit concentration

Sequencing and Analysis

Recommended data outputs and analysis examples are provided for reference only. For detailed information, please contact us to discuss your project-specific analysis requirements.

Platform Type	Illumina NovaSeq X Plus	PacBio Revio	Nanopore PromethION
Read Length	Paired-end 150 bp	> 15 kb (Average)	> 17 kb (Average)
Sequencing Depth	For rare diseases: 30-50×	For genetic diseases: 10-20×	For genetic diseases: 10-20×
Sequencing Depth	For tumor tissues: 50×; For adjacent normal tissues and blood: 30×	For tumor tissues: ≥20×	For tumor tissues: ≥20×
Standard Data｜ Analysis	Data quality control Alignment with reference genome SNP/InDel/SV/CNV detection Somatic SNP/InDel/SV/CNV detection (For tumor-normal paired samples)	Data quality control Sequence alignment Structural variant (SV) detection Variation annotation

Note: Values of sequencing depths are only listed for your reference. Download the Service Specifications to learn more. For detailed information, please contact us for your customized requests.

Sequencing and Analysis

Recommended data outputs and analysis examples are provided for reference only. For detailed information, please contact us to discuss your project-specific analysis requirements.

Platform Type	Illumina NovaSeq X Plus	PacBio Revio	Nanopore PromethION
Read Length	Paired-end 150 bp	> 15 kb (Average)	> 17 kb (Average)
Sequencing Depth	For rare diseases: 30-50×	For genetic diseases: 10-20×	For genetic diseases: 10-20×
Sequencing Depth	For tumor tissues: 50×; For adjacent normal tissues and blood: 30×	For tumor tissues: ≥20×	For tumor tissues: ≥20×
Standard Data｜ Analysis	Data quality control Alignment with reference genome SNP/InDel/SV/CNV detection Somatic SNP/InDel/SV/CNV detection (For tumor-normal paired samples)	Data quality control Sequence alignment Structural variant (SV) detection Variation annotation

Note: Values of sequencing depths are only listed for your reference. Download the Service Specifications to learn more. For detailed information, please contact us for your customized requests.

Sequencing and Analysis

Recommended data outputs and analysis examples are provided for reference only. For detailed information, please contact us to discuss your project-specific analysis requirements.

Platform Type	Illumina NovaSeq X Plus	PacBio Revio	Nanopore PromethION
Read Length	Paired-end 150 bp	> 15 kb (Average)	> 17 kb (Average)
Sequencing Depth	For rare diseases: 30-50×	For genetic diseases: 10-20×	For genetic diseases: 10-20×
Sequencing Depth	For tumor tissues: 50×; For adjacent normal tissues and blood: 30×	For tumor tissues: ≥20×	For tumor tissues: ≥20×
Standard Data｜ Analysis	Data quality control Alignment with reference genome SNP/InDel/SV/CNV detection Somatic SNP/InDel/SV/CNV detection (For tumor-normal paired samples)	Data quality control Sequence alignment Structural variant (SV) detection Variation annotation

Note: Values of sequencing depths are only listed for your reference. Download the Service Specifications to learn more. For detailed information, please contact us for your customized requests.

Sequencing and Analysis

Recommended data outputs and analysis examples are provided for reference only. For detailed information, please contact us to discuss your project-specific analysis requirements.

Platform Type	Illumina NovaSeq X Plus	PacBio Revio	Nanopore PromethION
Read Length	Paired-end 150 bp	> 15 kb (Average)	> 17 kb (Average)
Sequencing Depth	For rare diseases: 30-50×	For genetic diseases: 10-20×	For genetic diseases: 10-20×
Sequencing Depth	For tumor tissues: 50×; For adjacent normal tissues and blood: 30×	For tumor tissues: ≥20×	For tumor tissues: ≥20×
Standard Data｜ Analysis	Data quality control Alignment with reference genome SNP/InDel/SV/CNV detection Somatic SNP/InDel/SV/CNV detection (For tumor-normal paired samples)	Data quality control Sequence alignment Structural variant (SV) detection Variation annotation

Note: Values of sequencing depths are only listed for your reference. Download the Service Specifications to learn more. For detailed information, please contact us for your customized requests.

Resources

Example Analysis Output

1/1

Sequencing Depth

Review sequencing depth distribution across samples to assess data quality and analysis readiness.

1/1

Chromosome Coverage

Assess average depth and coverage across chromosomes to evaluate sequencing uniformity.

1/1

Genome-wide View

Visualise variant patterns across chromosomes using an integrated Circos-style summary.

1/1

Somatic SVs

Compare somatic structural variant types across samples in tumour-normal studies.

1/1

Mutational Signatures

Explore mutation patterns associated with cancer biology and underlying mutational processes.

Webinars

Getting Started with Genomics: Next Generation Sequencing Essentials for 2024

Discover the fundamentals of Next-Generation Sequencing (NGS) and learn how leading technologies such as Illumina, PacBio, and Oxford Nanopore are advancing genomic research and unlocking new possibilities in DNA analysis.

Learn More

Frequently Asked Questions

What coverage depth do hWGS projects require?

Most germline hWGS projects use 30× coverage to support reliable detection of SNVs and InDels. Researchers often choose higher coverage when they study mosaic variants, low-frequency alleles, or clinical research samples.

Which variant types does hWGS detect?

How does hWGS differ from whole exome sequencing (WES)?

How do researchers use hWGS in rare and undiagnosed disease studies?

How do teams process and quality-control hWGS data?

How do researchers apply hWGS in population genetics studies?

How do hWGS projects scale to large cohorts?

Explore Genomics Insights

Access webinars, brochures and case studies covering sequencing technologies, study planning and data interpretation.

Speak with a Specialist

Have a project in mind?

Send us your enquiry and a Novogene Europe specialist will be in touch.